本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kura Oncology, Inc

7.95
+0.05000.63%
盘后8.110.1600+2.01%18:06 EDT
成交量:186.46万
成交额:1,503.64万
市值:6.90亿
市盈率:-3.52
高:8.30
开:7.99
低:7.91
收:7.90
52周最高:21.57
52周最低:5.41
股本:8,679.72万
流通股本:6,398.56万
量比:1.05
换手率:2.91%
股息:- -
股息率:- -
每股收益(TTM):-2.2592
每股收益(LYR):-2.0193
净资产收益率:-51.11%
总资产收益率:-22.93%
市净率:2.26
市盈率(LYR):-3.94

数据加载中...

2023/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/03

重要事件披露

Form 8-K - Current report
2023/06/15

重要事件披露

Form 8-K - Current report
2023/06/12

重要事件披露

Form 8-K - Current report
2023/06/02

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/06/02

重要事件披露

Form 8-K - Current report
2023/05/10

重要事件披露

Form 8-K - Current report
2023/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/19

重要事件披露

8-K - Current report
2023/03/10

重要事件披露

8-K - Current report
2023/02/24

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/23

重要事件披露

8-K - Current report
2023/02/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals